These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 22266304)

  • 1. Low pH formulation of whole IgG antivenom: impact on quality, safety, neutralizing potency and viral inactivation.
    Solano S; Segura Á; León G; Gutiérrez JM; Burnouf T
    Biologicals; 2012 Mar; 40(2):129-33. PubMed ID: 22266304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of the impact of solvent/detergent treatment on the quality and potency of a whole IgG equine antivenom.
    Segura A; León G; Su CY; Gutiérrez JM; Burnouf T
    Biologicals; 2009 Oct; 37(5):306-12. PubMed ID: 19540775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stability of equine IgG antivenoms obtained by caprylic acid precipitation: towards a liquid formulation stable at tropical room temperature.
    Segura A; Herrera M; González E; Vargas M; Solano G; Gutiérrez JM; León G
    Toxicon; 2009 May; 53(6):609-15. PubMed ID: 19673074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single-reagent one-step procedures for the purification of ovine IgG, F(ab')2 and Fab antivenoms by caprylic acid.
    Al-Abdulla I; Casewell NR; Landon J
    J Immunol Methods; 2014 Jan; 402(1-2):15-22. PubMed ID: 24246428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of whole IgG equine antivenom: comparison between normal and envenomed rabbits.
    Quesada L; Sevcik C; Lomonte B; Rojas E; Gutiérrez JM
    Toxicon; 2006 Sep; 48(3):255-63. PubMed ID: 16863656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of preservatives on IgG aggregation, complement-activating effect and hypotensive activity of horse polyvalent antivenom used in snakebite envenomation.
    García M; Monge M; León G; Lizano S; Segura E; Solano G; Rojas G; Gutiérrez JM
    Biologicals; 2002 Jun; 30(2):143-51. PubMed ID: 12127316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of viral inactivation during pH 3.3 pepsin digestion and caprylic acid treatment of antivenoms.
    Burnouf T; Terpstra F; Habib G; Seddik S
    Biologicals; 2007 Oct; 35(4):329-34. PubMed ID: 17363271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Purification of equine whole IgG snake antivenom by using an aqueous two phase system as a primary purification step.
    Vargas M; Segura Á; Villalta M; Herrera M; Gutiérrez JM; León G
    Biologicals; 2015 Jan; 43(1):37-46. PubMed ID: 25458474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antivenoms for the treatment of snakebite envenomings: the road ahead.
    Gutiérrez JM; León G; Burnouf T
    Biologicals; 2011 May; 39(3):129-42. PubMed ID: 21429763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Inactivation of BVDV (experimental model for hepatitis C) using low pH and heat treatment in intravenous human immunoglobulins].
    Ruibal Brunet IJ; Noa Romero E; Rivero Mas AT; Martín García RZ
    Sangre (Barc); 1999 Oct; 44(5):352-6. PubMed ID: 10618912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticomplementary activity of equine whole IgG antivenoms: comparison of three fractionation protocols.
    León G; Lomonte B; Gutiérrez JM
    Toxicon; 2005 Jan; 45(1):123-8. PubMed ID: 15581691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-human erythrocyte antibodies in horse-derived antivenoms used in the treatment of snakebite envenomations.
    León G; Rodríguez MA; Rucavado A; Lomonte B; Gutiérrez JM
    Biologicals; 2007 Mar; 35(1):5-11. PubMed ID: 16490363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of snake antivenom purity by comparing physicochemical and immunochemical methods.
    Segura A; Herrera M; Villalta M; Vargas M; Gutiérrez JM; León G
    Biologicals; 2013 Mar; 41(2):93-7. PubMed ID: 23190453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of an improved method for production of antiscorpion F(ab')2 fragment of IgG with high yield and potency.
    Seddik SS; Wanas S; Shehata A; Fawaz S; Helmy MH
    J Nat Toxins; 2002 May; 11(2):123-32. PubMed ID: 12009112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Viral safety of Nanogam, a new 15 nm-filtered liquid immunoglobulin product.
    Terpstra FG; Parkkinen J; Tölö H; Koenderman AH; Ter Hart HG; von Bonsdorff L; Törmä E; van Engelenburg FA
    Vox Sang; 2006 Jan; 90(1):21-32. PubMed ID: 16359352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of passive haemagglutination (PHA) and haemagglutination inhibition (HAI) technique for potency estimation of Cobra Antisnake Venom Serum (ASVS).
    Pradhan S; Kumar S; Singh D; Sood RC; Sehgal R
    Biologicals; 2007 Jun; 35(3):155-60. PubMed ID: 17088076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the effect of Crotalus simus and Crotalus durissus ruruima venoms on the equine antibody response towards Bothrops asper venom: implications for the production of polyspecific snake antivenoms.
    Dos-Santos MC; Arroyo C; Solano S; Herrera M; Villalta M; Segura A; Estrada R; Gutiérrez JM; León G
    Toxicon; 2011 Feb; 57(2):237-43. PubMed ID: 21130107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cross-neutralisation of Australian brown snake, taipan and death adder venoms by monovalent antibodies.
    Isbister GK; O'Leary MA; Hagan J; Nichols K; Jacoby T; Davern K; Hodgson WC; Schneider JJ
    Vaccine; 2010 Jan; 28(3):798-802. PubMed ID: 19879227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human heterophilic antibodies against equine immunoglobulins: assessment of their role in the early adverse reactions to antivenom administration.
    León G; Segura A; Herrera M; Otero R; França FO; Barbaro KC; Cardoso JL; Wen FH; de Medeiros CR; Prado JC; Malaque CM; Lomonte B; Gutiérrez JM
    Trans R Soc Trop Med Hyg; 2008 Nov; 102(11):1115-9. PubMed ID: 18561967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neutralization of four Peruvian Bothrops sp. snake venoms by polyvalent antivenoms produced in Perú and Costa Rica: preclinical assessment.
    Rojas E; Quesada L; Arce V; Lomonte B; Rojas G; Gutiérrez JM
    Acta Trop; 2005 Jan; 93(1):85-95. PubMed ID: 15589801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.